Recent Updates
Recently added Catalysts
ILMN Positive Sentiment Score: 75/100

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

Key Takeaway: Illumina, Inc. announced that the Chinese Ministry of Commerce will lift the export ban imposed on the company since March 2025. The ban will officially end on November 10, although Illumina remains on the Unreliable Entities List, requiring government approval for purchases. CEO Jacob Thaysen expressed optimism about the announcement and the company's commitment to resolving its status in China.
Price reaction · baseline $122.44 (2025-11-05 close) · hit after-hours · 2 other ILMN headline(s) in the window, move may be shared
day 0 close · peak
-1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Export ban on Illumina to be lifted, allowing market access.
  • Commitment to resolving issues with the Unreliable Entities List.
  • Positive engagement with Chinese authorities and stakeholders.
  • Long-standing partnership with customers in China.

Full Press Release Details

SAN DIEGO,Nov. 5, 2025/PRNewswire/ -- The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ:ILMN), which had been in place since March 4, 2025. While the ban will be lifted on November 10, Illumina remains on the Unreliable Entities List (UEL), requiring government approval for instrument purchases.
Illumina remains focused on achieving a positive resolution regarding its inclusion on the UEL and is committed to serving customers in this important market. For two decades, Illumina has been proud to partner with customers in China to advance genomics and improve human health.
"We are pleased with the announcement from MOFCOM, which is a very positive step forward. Illumina will continue to engage with authorities and stakeholders as we work toward a long-term resolution," said Jacob Thaysen, CEO of Illumina. "I want to thank our customers for their trust and support, and our team in China and around the world for their dedication and resilience."
Illumina is making no change to FY25 guidance, which was recently updated during the company's Q3 2025 earnings call.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visitillumina.comand connect with us onX,Facebook,LinkedIn,Instagram,TikTok, and YouTube.

Frequently Asked Questions

When will the export ban on Illumina be lifted?

The export ban will be lifted on November 10, 2025.

Is Illumina still on the Unreliable Entities List?

Yes, Illumina remains on the Unreliable Entities List and needs government approval for purchases.

What is Illumina's focus in China?

Illumina is focused on achieving a positive resolution regarding its status and serving customers.

What did Illumina's CEO say about the announcement?

CEO Jacob Thaysen expressed optimism and gratitude for customer support and team dedication.

Last updated: Nov 5, 2025